Cargando…
Co-treatment with Esculin and erythropoietin protects against renal ischemia–reperfusion injury via P2X7 receptor inhibition and PI3K/Akt activation
Renal ischemia/reperfusion (RI/R) is a critical clinical outcome with slightly reported improvement in mortality and morbidity. Effective therapies are still crucially required. Accordingly, the therapeutic effects of esculin (ESC, LCESI-MS/MS-isolated compound from Vachellia farnesiana flowers extr...
Autores principales: | El-Maadawy, Walaa H., Hassan, Marwa, Hafiz, Ehab, Badawy, Mohamed H., Eldahshan, Samir, AbuSeada, AbdulRahman, El-Shazly, Maha A. M., Ghareeb, Mosad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010483/ https://www.ncbi.nlm.nih.gov/pubmed/35422072 http://dx.doi.org/10.1038/s41598-022-09970-8 |
Ejemplares similares
-
Chemical Profiling of Polyphenolics in Eucalyptus globulus and Evaluation of Its Hepato–Renal Protective Potential Against Cyclophosphamide Induced Toxicity in Mice
por: Ghareeb, Mosad A., et al.
Publicado: (2019) -
Pharmacological activities of esculin and esculetin: A review
por: Cai, Ting, et al.
Publicado: (2023) -
Esculin improves dyslipidemia, inflammation and renal damage in streptozotocin-induced diabetic rats
por: Wang, Yue-Hua, et al.
Publicado: (2015) -
Comparison of the Protective Effects of Erythropoietin and Melatonin on Renal Ischemia-Reperfusion Injury
por: Banaei, Shokofeh, et al.
Publicado: (2016) -
Comparison of carbamylated versus recombinant erythropoietin during spinal cord ischemia/reperfusion injury
por: Simon, F, et al.
Publicado: (2010)